Clinical Trial Update: The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study [Phase 3]

View source ↗

Summary

Phase 3 trial update for the OLYMPUS study evaluating optimized delivery of mitomycin for upper tract urothelial carcinoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma Transitional Cell
• Transitional Cell Carcinoma of Renal Pelvis

Drugs mentioned

• Mitomycin (Mitomycin)

Snippet

Sponsor: UroGen Pharma Ltd. | Conditions: Carcinoma, Transitional Cell, Transitional Cell Carcinoma of Renal Pelvis | Phase 3 | Status: COMPLETED | Results posted: 2020-11-20